Iverheal 12mg is a pharmaceutical formulation of ivermectin, an antiparasitic medication commonly used to treat various parasitic infections in humans. Ivermectin has been effective against conditions such as strongyloidiasis, onchocerciasis (river blindness), and certain types of scabies. Iverheal 12mg typically contains 12 milligrams of ivermectin as its active ingredient, making it suitable for adults and children over a certain weight, depending on the specific health guidelines.

Iverheal works by binding to specific receptors in the nervous system of the parasites, leading to paralysis and eventual death of the organisms. This mechanism of action makes it an effective treatment option for a range of parasitic infections. The medication is usually administered as a single oral dose, and its efficacy is often enhanced when taken under the guidance of a healthcare professional.

While Iverheal is generally well-tolerated, it can cause side effects in some individuals. Common side effects may include dizziness, nausea, diarrhea, and skin rashes. More serious side effects, though rare, can occur, particularly in patients with heavy parasitic infections, leading to a phenomenon known as the "Mazzotti reaction," which can cause inflammation and discomfort.

It is crucial for patients to consult healthcare providers before using Iverheal 12mg to ensure it is appropriate for their specific condition and to receive proper dosing instructions. Additionally, due to the rise of misinformation during the COVID-19 pandemic, it is important to note that Iverheal is not approved for the treatment of viral infections such as COVID-19. Overall, Iverheal 12mg remains a valuable treatment option for certain parasitic infections when used responsibly and under medical supervision.